<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Pan Afr Med J</journal-id>
      <journal-id journal-id-type="iso-abbrev">Pan Afr Med J</journal-id>
      <journal-id journal-id-type="publisher-id">PAMJ</journal-id>
      <journal-title-group>
        <journal-title>The Pan African Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1937-8688</issn>
      <publisher>
        <publisher-name>The African Field Epidemiology Network</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25018799</article-id>
      <article-id pub-id-type="pmc">4085949</article-id>
      <article-id pub-id-type="publisher-id">PAMJ-17-49</article-id>
      <article-id pub-id-type="doi">10.11604/pamj.2014.17.49.3246</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Vancomyc&#x131;n res&#x131;stant enterococcus bacterem&#x131;a &#x131;n a pat&#x131;ent w&#x131;th <italic>Pneumocystis jiroveci</italic> pneumon&#x131;a, granulocyst&#x131;c sarcoma and acute resp&#x131;ratory d&#x131;stress syndrome</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Emre</surname>
            <given-names>Julide Celdir</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Baysak</surname>
            <given-names>Aysegul</given-names>
          </name>
          <xref ref-type="aff" rid="AF0002">2</xref>
          <xref ref-type="corresp" rid="cor1">&amp;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Oz</surname>
            <given-names>Adnan Tolga</given-names>
          </name>
          <xref ref-type="aff" rid="AF0002">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ece</surname>
            <given-names>Gulfem</given-names>
          </name>
          <xref ref-type="aff" rid="AF0003">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Arda</surname>
            <given-names>Bilgin</given-names>
          </name>
          <xref ref-type="aff" rid="AF0004">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bacakoglu</surname>
            <given-names>Feza</given-names>
          </name>
          <xref ref-type="aff" rid="AF0005">5</xref>
        </contrib>
      </contrib-group>
      <aff id="AF0001"><label>1</label>Turgutlu State Hospital, Department of Chest Diseases, Manisa, Turkey</aff>
      <aff id="AF0002"><label>2</label>Izmir University School of Medicine, Department of Chest Diseases, Izmir, Turkey</aff>
      <aff id="AF0003"><label>3</label>Izmir University School of Medicine, Department of Medical Microbiology, Izmir, Turkey</aff>
      <aff id="AF0004"><label>4</label>Ege University School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Izmir, Turkey</aff>
      <aff id="AF0005"><label>5</label>Ege University School of Medicine, Department of Chest Diseases, Izmir, Turkey</aff>
      <author-notes>
        <corresp id="cor1"><label>&amp;</label>Corresponding author: Aysegul Baysak, Izmir University School of Medicine, Department of Chest Diseases, Izmir, Turkey</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>23</day>
        <month>1</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <volume>17</volume>
      <elocation-id>49</elocation-id>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>8</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>24</day>
          <month>11</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Julide Celdir Emre et al.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/">
          <license-p>The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>In this case report we aimed to present a patient with granulocytic sarcomaa, neutropenic fever, ARDS and Pneumocystis jirovecii pneumoniae that was hospitalized in our intensive care unit. The patient recovered and then developed vancomycin resistant enterococci (VRE) bacteremia due to port catheter during follow up. The patient had risk factors for VRE bacteremia and he was administered linezolide without removing the catheter. He was discharged with recovery.</p>
      </abstract>
      <kwd-group>
        <kwd>Granulocystic sarcoma</kwd>
        <kwd>Pneumocystis jiroveci pneumoniae</kwd>
        <kwd>vancomycin resistant enterococci</kwd>
        <kwd>(VRE)</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="S0001">
      <title>Introduction</title>
      <p>Granulocytic sarcoma is a rare extramedullary tumor that originates from granulocytic cells. Granulocytic sarcoma may develop during acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative disorders. It is usually detected on skin,bones, soft tissue and periost layer. It is common in children and adolescents and equally shown in both genders. This is a sign of bad prognosis [<xref rid="CIT0001" ref-type="bibr">1</xref>]. Surgical excision, combined chemotherapy, and radiotherapy are treatment models [<xref rid="CIT0002" ref-type="bibr">2</xref>]. Allogenic or autologous bone marrow transplantation are additional treatment to systemic chemotherapy in case of coexistence of acute leukemia and granulocytic sarcomae [<xref rid="CIT0001" ref-type="bibr">1</xref>]. Recently immunosuppressed cases have increased due to an increment in cytotoxic and corticosteroid treatment (organ transplantation, systemic disorders, etc.) [<xref rid="CIT0003" ref-type="bibr">3</xref>, <xref rid="CIT0004" ref-type="bibr">4</xref>]. Neutropenia is defined as neutrophil count less than 500/mm<sup>3</sup>or decreasing under 500/mm<sup>3</sup> in 24-48 hours. Febril neutropenia, is defined as fever higher than 38.3&#xB0;C or higher than 38&#xB0;C during one hour [<xref rid="CIT0003" ref-type="bibr">3</xref>]. Pulmonary complications are ictu causes of morbidity and mortality in immunosuppressed cases. In these cases mortality develops depending on underlying disorders, infectious agent and type of complication. Early diagnosis, and treatment are important and multidiciplinary approach is needed. Prematures, children with primary immunodefiency, hematological malignities, organ transplantation, immunosuppresive treatment are under risk of P.jirovecii infection other than AIDS. <italic>Pneumocystis jiroveci</italic> pneumoniae is a clinical icture with diffuse interstitial infiltration. Besides normal pulmonary X-ray, cystic form with increased risk of spontanous pneumothorax, paranchymal consolidation, multiple nodules, pleural fluid, and enlargement of lymph nodes may be other radiological images [<xref rid="CIT0005" ref-type="bibr">5</xref>]. Enterococcal infections have increased due to increment in third generation cephalosporin use in 1970s. First isolation of VRE was in 1978 and then globally spreaded and became one of the most important reason of hospital infection. <italic>Enterecoccus feacalis</italic> and <italic>Enterecoccus faecium</italic> are the most common strains [<xref rid="CIT0006" ref-type="bibr">6</xref>]. In this case report we aimed to present a patient with granulocytic sarcomae, neutropenic fever, acute respiratory distress syndrome (ARDS) and Pneumocystis jiroveci pneumoniae that was hospitalized in our intensive care unit.</p>
    </sec>
    <sec id="S0002">
      <title>Patient and observation</title>
      <p>Nineteen year old male patient had left arm pain two months ago and afterwards he was diagnosed as granulocytic sarcoma. On the seventh day of his chemotherapy neutropenic fever developed. He was administered piperacillin/tazobactam, amikacin; but fever continued and teicoplanin was initiated. Then the antibiotics were stopped and amphothericin B and meropenem was begun. On the twentyfifith day of the chemotherapy regime neutropenic state ended. He developed fever, dyspnea and hypotension on the 27th day. His physical examination showed cyanosis, dyspnea, increased respiratory sound at the upper and middle lung level bilaterally. The arterial blood gas analysis revealed severe hypoxemia (PaO2/FiO2: 82.5) and he was entubated. The patient was transffered to intensive care unit and mechanical ventilation support was applied. The chest X-ray revealed bilaterally increased non-homogeneous density on all zones (<xref ref-type="fig" rid="F0001">Figure 1</xref>). High Resolution computerized tomography indicated frost glass appearance (<xref ref-type="fig" rid="F0002">Figure 2</xref>). No growth was reported on microbiological cultures. <italic>Pneumocytis jiroveci</italic> pneumoniae was not detected on broncho alveolar lavage sample by Giemsa stain and trimethoprim/sulfamethoxazole (TMP/SMX) 80mg/day was iniated. Clinical and radiological recovery was obtained (<xref ref-type="fig" rid="F0003">Figure 3</xref>). Mechanical ventilation support was stopped on the nineth day. Fever increased on twelveth day. Vancomycin resistant <italic>Enterecoccus feacalis</italic> was detected on blood culture taken from the port catheter and evaluated as hospital infection. Strict infection control measures were taken and the patient was administered linezolide. Peripheral and catheter blood cultures were drawn in 48-72 hours before the removal of the port catheter. The patient was discharged on the twentyfourth day with recovery.</p>
      <fig id="F0001" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>The chest X-ray image revealed bilaterally increased non-homogeneous density on all zones</p>
        </caption>
        <graphic xlink:href="PAMJ-17-49-g001"/>
      </fig>
      <fig id="F0002" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <p>High resolution computerized tomography (HRCT) image of the patient</p>
        </caption>
        <graphic xlink:href="PAMJ-17-49-g002"/>
      </fig>
      <fig id="F0003" orientation="portrait" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Radiological recovery of the patient on chest X-ray</p>
        </caption>
        <graphic xlink:href="PAMJ-17-49-g003"/>
      </fig>
    </sec>
    <sec sec-type="discussion" id="S0003">
      <title>Discussion</title>
      <p>
<italic>P. Jiroveci</italic> pneumoniae is a clinical picture in individuals with cellular immundeficiency and fever, cough, progressive hypoxemia and dyspnea develops. The clinical status of the patient may be severe. Diffuse interstitial and perihilar infiltration are typical on chest X-ray [<xref rid="CIT0007" ref-type="bibr">7</xref>]. Fever and dyspneae may appear a few days earlier. P. <italic>jiroveci</italic>cannot be detected on culture. The diagnosis can be done by direct microscopic examination of the lower respiratory tract samples with Giemsa and Wright stain and PCR. In our case report we could not show P. <italic>jiroveci</italic> on bronchoscopic samples and ampiric treatment was initiated considering hypoxemia and radiological image.</p>
      <p>The treatment of <italic>P. jiroveci</italic> pneumoniae requires TMP/SMX (15 mg/kg/day) for 14-21 days as the first line agent. In cases with mild to severe hypoxemia (PaO2 &lt; 70 mmHg) corticosteroid treatment potentiates oxygenation and decreases mortality. The recommended treatment requires 40 mg/day twice for 5 days, 40 mg/day for five days and 20 mg methylprednisolone for 11 days [<xref rid="CIT0003" ref-type="bibr">3</xref>]. In our case TMP-SMX and methylprednisolone were iniated and clinical and radiological recovery were obtained. Also dyspnea healed.</p>
      <p>Enterococci are a part of the gastrointestinal system and vaginal flora and infections are commonly due to endogeneous flora. The bacterial isolate is transferred to patients by contamianted hands and fomites. Recently there is an increment in nosocomial infections due to enterococci. VRE infections particulary increased in patients with underlying disorders. <italic>E. Faecium</italic> strains show 47% vancomycin resistance [<xref rid="CIT0008" ref-type="bibr">8</xref>, <xref rid="CIT0009" ref-type="bibr">9</xref>]. The risk factors for VRE infection are immunsuppression, long duration of hospitalization, and broad spectrum antibiotic. Our patient had all of these risk factors. VRE was reported on port catheter which was used to administer chemotherapy [<xref rid="CIT0009" ref-type="bibr">9</xref>]. Linezolid is the only member of synthetic oxyzolidone family and is active in-vitro against resistant Gram positive cocci such as vancomycin resistant <italic>Enterococcus faecalis</italic> and <italic>Enterococcus faecium</italic> and methicilin resistant <italic>Staphylococcus</italic> aureus [<xref rid="CIT0009" ref-type="bibr">9</xref>, <xref rid="CIT0010" ref-type="bibr">10</xref>]. The approval was declared in our country in 2005. Our case was treated with linezolide without removing the catheter.</p>
    </sec>
    <sec sec-type="conclusion" id="S0004">
      <title>Conclusion</title>
      <p>Chemotherapy and other treatment modalities have increased survey; but long duration of hospitalization, and broad spectrum antibiotic use increase the risk of resistant infections. Appropiate microbiological culture and multidiciplinary approach can decrease mortality.</p>
    </sec>
  </body>
  <back>
    <sec id="S0005">
      <title>Competing interests</title>
      <p>The authors declare no competing interest.</p>
    </sec>
    <sec id="S0006">
      <title>Authors&#x2019; contributions</title>
      <p>Celdir Emre and Oz were doctors responsible for this patient. Ece carried out microbiologycal analysis. Arda was the doctor from the department of Infectious Diseases who monitors us with this case. Celdir Emre, Baysak and Ece were major contributors to writing the manuscript and to the conception and design as well as drafting the article for publication. Bacakoglu supervised the redaction of this article. All the authors have read and approved the final version of the manuscript</p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="CIT0001">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Finnegan</surname>
              <given-names>DPJ</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>FGC</given-names>
            </name>
            <name>
              <surname>McMullin</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>Acute myeloid leukemia with concurrent myeloid sarcomaa treated with autologous bone marrow transplantion:two illustrative cases and a literature review</article-title>
          <source>Hematol Oncol.</source>
          <year>2005</year>
          <volume>23</volume>
          <issue>3,4</issue>
          <fpage>133</fpage>
          <lpage>135</lpage>
          <pub-id pub-id-type="pmid">16273593</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0002">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dutta Roy</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Stafford</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Scally</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Selvachandran</surname>
              <given-names>SN</given-names>
            </name>
          </person-group>
          <article-title>Granulocytic sarcomaa of the breast antedating acute myelogenous leukemia</article-title>
          <source>Breast.</source>
          <year>2004</year>
          <volume>13</volume>
          <issue>3</issue>
          <fpage>242</fpage>
          <lpage>246</lpage>
          <pub-id pub-id-type="pmid">15177430</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0003">
        <label>3</label>
        <element-citation publication-type="confproc">
          <article-title>T&#xFC;rk Toraks Dernegi Bagisikligi Baskilanmis Eriskinlerde Gelisen Pn&#xF6;moni Tani ve Tedavi Rehberi</article-title>
          <year>2009</year>
        </element-citation>
      </ref>
      <ref id="CIT0004">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rano</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Agusti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sibila</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Torres</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary infections in non-HIV immunocompromised patients</article-title>
          <source>Curr Opin Pulm Med.</source>
          <year>2005</year>
          <volume>11</volume>
          <issue>3</issue>
          <fpage>213</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">15818182</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0005">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Franquet</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gimenez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hidalgo</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Imaging of opportunistic fungal infections in immunocompromised patients</article-title>
          <source>Eur J Radiol.</source>
          <year>2004</year>
          <volume>51</volume>
          <issue>2</issue>
          <fpage>130</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">15246518</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0006">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akalin</surname>
              <given-names>Erdal</given-names>
            </name>
          </person-group>
          <article-title>Ge&#xE7;misten Gelecege Yogun Bakim Infeksiyonlari</article-title>
          <source>Yogun Bakim Dergisi</source>
          <year>2007</year>
          <volume>7</volume>
          <issue>1</issue>
          <fpage>5</fpage>
          <lpage>8</lpage>
        </element-citation>
      </ref>
      <ref id="CIT0007">
        <label>7</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>De Pauw</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Verweij</surname>
              <given-names>PE</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Mandell</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Dolin</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Infections in patients with hematologic malignancies</article-title>
          <article-title>Principles and Practice of Infectious Diseases</article-title>
          <year>2005</year>
          <publisher-name>Elsevier Inc</publisher-name>
          <fpage>3432</fpage>
          <lpage>41</lpage>
        </element-citation>
      </ref>
      <ref id="CIT0008">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tasbakan</surname>
              <given-names>IM</given-names>
            </name>
          </person-group>
          <article-title>Vankomisine diren&#xE7;li enterekok olgular?</article-title>
          <source>ANKEM Derg</source>
          <year>2010</year>
          <volume>24</volume>
          <issue>Ek 2</issue>
          <fpage>82</fpage>
          <lpage>4</lpage>
        </element-citation>
      </ref>
      <ref id="CIT0009">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Usluer</surname>
              <given-names>Gaye</given-names>
            </name>
          </person-group>
          <article-title>Linezolid</article-title>
          <source>ANKEM Derg</source>
          <year>2010</year>
          <volume>24</volume>
          <issue>Ek 2</issue>
          <fpage>114</fpage>
          <lpage>8</lpage>
        </element-citation>
      </ref>
      <ref id="CIT0010">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ulusoy</surname>
              <given-names>Sercan</given-names>
            </name>
          </person-group>
          <article-title>Yogun bakim &#xFC;nitesinde Gram-pozitif mikroorganizmalar ve diren&#xE7; sorunu</article-title>
          <source>Yogun bakim Derg 3.2</source>
          <year>2003</year>
          <fpage>118</fpage>
          <lpage>128</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
